Northland Capital Markets Upgrades Protagonist Therapeutics (PTGX) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: PTGX) | Delayed: 144.41 +2.27 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.14 | 52 Week High | $24.52 | |||
| Open | $144.03 | 52 Week Low | $10.02 | |||
| Day High | $146.44 | P/E | N/A | |||
| Day Low | $142.87 | EPS | $0.00 | |||
| Volume | 104,963 | |||||
